Reliability note

Titles and AI summaries are unofficial English monitoring aids, not legal advice or official translations. Each link opens the original Japanese official source, which remains authoritative.

PMDA announces web survey on essential-edition medicine and vaccine guides

薬・ワクチンのガイド(必須版)のWebアンケート調査を開始しました

Published: 2026-11-20 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Low · First detected by this dashboard: 2026-11-21

View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard

AI summary

Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.

Summary

On 2026-11-20, the Pharmaceuticals and Medical Devices Agency (PMDA) announced a web survey about its essential-edition guides for patients using medicines and people receiving vaccines. These guides, first provided in late April 2026, summarize information particularly important when using medicines or vaccines; the survey concerns readability and other user feedback. The stated survey period is 2026-11-20 through the end of December 2026, provisionally, with multiple-choice responses taking approximately 5–10 minutes via a link at the bottom of each guide. Supporting committee materials describe a two-part approach comprising an essential edition generally limited to one or two A4 pages and a detailed edition, with priority given to preparing and distributing the essential edition. This is a survey announcement, not an announcement of a new legal obligation.

Business Impact

The survey may inform improvements relevant to patients, their families, healthcare professionals using the guides to explain medicines, and marketing authorization holders that prepare the product guides. The supporting materials connect user-needs surveys with improvements to essential editions and further consideration of detailed editions.

Recommended Action

Marketing authorization holders and healthcare professionals using these guides could review the essential editions for readability and accessibility, including the survey link at the bottom of each guide. Any review of future guide-development plans could distinguish the committee's described approach from confirmed legal requirements.